Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Characterization of CEBPA Mutations and Promoter Hypermethylation in Pediatric Acute Myeloid Leukemia.

Iris H.I.M. Hollink, MD, Marry M. van den Heuvel-Eibrink, MD, PhD, Susan T.C.J.M. Arentsen-Peters, Martin Zimmermann, PhD, Justine K. Peeters, PhD, Peter J. Valk, PhD, Brian V. Balgobind, MD, Gertjan J.L. Kaspers, MD, PhD, Evelina S.J.M. de Bont, MD, PhD, Siebold S.N. de Graaf, MD, PhD, Jan Trka, PhD, Jan Stary, MD, PhD, Jean-Michel Cayuela, PhD, Andre Baruchel, MD, PhD, Ursula Creutzig, MD, PhD, Dirk Reinhardt, MD, PhD, Rob Pieters, MD, PhD, C. Michel Zwaan, MD, PhD

Blood (2009) 114 (22): 1605.

https://doi.org/10.1182/blood.V114.22.1605.1605

Published: 2009

Journal Articles

Identification of Gene Expression Signatures Accurately Predicting Cytogenetic Subtypes in Pediatric Acute Myeloid Leukemia.

Brian V Balgobind, MD, Marry M van den Heuvel-Eibrink, MD, PhD, Renee X Menezes, Dirk Reinhardt, MD, PhD, Iris H.I.M. Hollink, MD, Susan T.J.C.M. Arentsen-Peters, Elisabeth R van Wering, Gertjan Kaspers, MD, PhD, Jaqueline Cloos, PhD, Eveline S.J.M de Bont, Andre Baruchel, MD, Jean-Michel Cayuela, PhD, Jan Stary, MD, PhD, Jan Trka, MD., PhD, Berna Beverloo, PhD, Rob Pieters, Christian M Zwaan, MD, PhD, Monique L. Den Boer, MSc, PhD

Blood (2008) 112 (11): 1509.

https://doi.org/10.1182/blood.V112.11.1509.1509

Published: 2008

Journal Articles

EVI1 Overexpression in Pediatric Acute Myeloid Leukemia Associated with Unfavorable Subtypes.

Brian V Balgobind, MD, Sanne Lugthart, MD, Iris H.I.M. Hollink, MD, Susan T.J.C.M. Arentsen-Peters, Elisabeth R van Wering, Sibold S.N. de Graaf, MD, PhD, Dirk Reinhardt, MD, PhD, Gertjan Kaspers, MD, PhD, Jan Stary, MD, PhD, Jan Trka, MD, PhD, Martin Zimmermann, PhD, Ruud Delwel, PhD, Rob Pieters, Christian M Zwaan, MD, PhD, Marry M van den Heuvel-Eibrink, MD, PhD

Blood (2008) 112 (11): 1802.

https://doi.org/10.1182/blood.V112.11.1802.1802

Published: 2008

Journal Articles

Wilms’ Tumor 1 Gene Mutations in Childhood Acute Myeloid Leukemia: A New Prognostic factor with Implications for MRD Detection

Iris H.I.M. Hollink, MD, Marry M. van den Heuvel-Eibrink, MD, PhD, Martin Zimmermann, PhD, Brian V. Balgobind, MD, Susan T.C.J.M. Arentsen-Peters, Mariel Alders, PhD, Andre Willasch, MD, PhD, Gertjan J.L. Kaspers, MD, PhD, Jan Trka, MD, PhD, Andre Baruchel, MD, PhD, Siebold S.N. de Graaf, MD, PhD, Ursula Creutzig, Rob Pieters, MD, PhD, Dirk Reinhardt, MD, PhD, C. Michel Zwaan, MD, PhD

Blood (2008) 112 (11): 144.

https://doi.org/10.1182/blood.V112.11.144.144

Published: 2008

Journal Articles

NF1 Microdeletions in Pediatric MLL -Rearranged AML and T-ALL: A Novel Mechanism for RAS Activation.

Brian V. Balgobind, MD, Pieter Van Vlierberghe, Iris H. Hollink, Ans M.W. van den Ouweland, H. Berna Beverloo, Joan N.R. Terlouw-Kromosoeto, Elisabeth R. van Wering, Gertjan J.L. Kaspers, Dirk Reinhardt, Martin Horstmann, Karel Hahlen, Rob Pieters, Christian M. Zwaan, Jules P.P. Meijerink, Marry M. van den Heuvel-Eibrink

Blood (2007) 110 (11): 757.

https://doi.org/10.1182/blood.V110.11.757.757

Published: 2007

NARROW

Characterization of CEBPA Mutations and Promoter Hypermethylation in Pediatric Acute Myeloid Leukemia.

Identification of Gene Expression Signatures Accurately Predicting Cytogenetic Subtypes in Pediatric Acute Myeloid Leukemia.

EVI1 Overexpression in Pediatric Acute Myeloid Leukemia Associated with Unfavorable Subtypes.

Wilms’ Tumor 1 Gene Mutations in Childhood Acute Myeloid Leukemia: A New Prognostic factor with Implications for MRD Detection

NF1 Microdeletions in Pediatric MLL -Rearranged AML and T-ALL: A Novel Mechanism for RAS Activation.

Email alerts

ASH Publications

American Society of Hematology

Characterization of CEBPA Mutations and Promoter Hypermethylation in Pediatric Acute Myeloid Leukemia.

Identification of Gene Expression Signatures Accurately Predicting Cytogenetic Subtypes in Pediatric Acute Myeloid Leukemia.

EVI1 Overexpression in Pediatric Acute Myeloid Leukemia Associated with Unfavorable Subtypes.

Wilms’ Tumor 1 Gene Mutations in Childhood Acute Myeloid Leukemia: A New Prognostic factor with Implications for MRD Detection

NF1 Microdeletions in Pediatric MLL -Rearranged AML and T-ALL: A Novel Mechanism for RAS Activation.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only